Drivers of AR Reprogramming and Therapeutic Sensitivity in Prostate Cancer

Presented by
Christopher Barbieri, MD, PhD
Peter M. Sacerdote Distinguished Associate Professor
in Urologic Oncology
Associate Professor of Cell and Developmental Biology
Weill Cornell Medicine

Dr. Christopher Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer.